1. Home
  2. BNBX vs GNPX Comparison

BNBX vs GNPX Comparison

Compare BNBX & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied DNA Sciences Inc.

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$1.56

Market Cap

5.5M

ML Signal

N/A

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$2.32

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNBX
GNPX
Founded
1983
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
6.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BNBX
GNPX
Price
$1.56
$2.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
280.3K
1.1M
Earning Date
02-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,136,935.00
N/A
Revenue This Year
$253.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.11
N/A
52 Week Low
$1.16
$1.71
52 Week High
$145.73
$55.00

Technical Indicators

Market Signals
Indicator
BNBX
GNPX
Relative Strength Index (RSI) 39.43 45.18
Support Level $1.50 $2.63
Resistance Level $1.73 $3.04
Average True Range (ATR) 0.16 0.43
MACD 0.04 0.04
Stochastic Oscillator 42.87 31.28

Price Performance

Historical Comparison
BNBX
GNPX

About BNBX Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: